SHAREHOLDERS' EQUITY (Tables)

6 Months Ended

Jun. 30, 2026

Stockholders' Equity Note [Abstract]

Schedule of option activity

		Number of options				Weighted average exercise price				Weighted average remaining contractual life				Aggregate intrinsic value
						$				Years				$

Options outstanding at the beginning of year			8,628,743				4.05				5.52				796
Options granted			23,600				1.90
Options exercised			(142,435	)			1.04								202
Options forfeited			(105,369	)			1.42
Options expired			(722,330	)			4.28

Options outstanding as of June 30, 2026			7,682,209				4.02				5.20				2,324

Exercisable as of June 30, 2026			5,882,971				4.74				4.23				1,190

Schedule of weighted-average assumptions used to estimate fair value of options granted

		Six months ended June 30,
		2026				2025
		Unaudited

Volatility			87.1%-91.4	%			90.6%-91.0	%
Risk-free interest rate			3.76%-4.02	%			4.07%-4.37	%
Dividend yield			0	%			0	%
Expected life (years)			4.13-5.01				4.14

Schedule of RSUs activity

		Number of RSUs				Weighted average grant date per value
						$

RSUs outstanding at the beginning of year			567,400				1.57
RSUs granted			19,200				1.96
RSUs vested			(29,645	)			1.70
RSUs forfeited			(28,442	)			1.61
RSUs net settled			(388	)			1.69

Unvested RSUs outstanding as of June 30, 2026			528,125				1.58

Schedule of share-based payment arrangement, expensed and capitalized

		2026				2025
		Unaudited
Research and development expenses		$	210			$	454
Marketing and business development expenses			29				52
General and administrative expenses			331				481

Total operating expense		$	570			$	987